title: Calcineurin deficiency decreases inflammatory lesions in transforming growth factor beta1-deficient mice.
abstract: Transforming growth factor (TGF) beta1) is an immunoregulatory cytokine involved in self-tolerance and lymphocyte homeostasis. Tgfb1 knock-out (KO) mice develop severe multi-focal autoimmune inflammatory lesions due to [Ca(2+)]i deregulation in T cells, and die within 3 weeks after birth. Because the calcineurin inhibitor FK506 inhibits the hyperresponsiveness of Tgfb1(-/-) thymocytes, and because calcineurin Abeta (CNAbeta)-deficient mice do not reject allogenic tumours, we have generated Tgfb1(-/-) Cnab(-/-) mice to address whether CNAbeta deficiency prevents T cell activation and inflammation in Tgfb1(-/-) mice. Here we show that in Tgfb1(-/-) Cnab(-/-) mice inflammation is reduced significantly relative to that in Tgfb1(-/-) mice. However, both CD4(+) and CD8(+) T cells in double knock-out (DKO) mice are activated, as revealed by up-regulation of CD11a lymphocyte function-associated antigen-1 (LFA-1), CD44 and CD69 and down-regulation of CD62L. These data suggest that deficiency of CNAbeta decreases inflammatory lesions but does not prevent activation of autoreactive T cells. Also Tgfb1(-/-) T cells can undergo activation in the absence of CNAbeta, probably by using the other isoform of calcineurin (CNAalpha) in a compensatory manner. CNAbeta-deficient T cells undergo spontaneous activation in vivo and are activated upon anti-T cell receptor stimulation in vitro. Understanding the role of calcineurin in T cell regulation should open up new therapeutic opportunities for inflammation and cancer.
authors.affiliation: BIO5 Institute, University of Arizona, Tucson, AZ 85724-5217, USA. ramiredb@email.arizona.edu
authors.forename: R
authors.initials: R
authors.lastname: Bommireddy
authors.forename: O F
authors.initials: OF
authors.lastname: Bueno
authors.forename: J
authors.initials: J
authors.lastname: Martin
authors.forename: I
authors.initials: I
authors.lastname: Ormsby
authors.forename: H
authors.initials: H
authors.lastname: Chen
authors.forename: C
authors.initials: C
authors.lastname: Gard
authors.forename: J D
authors.initials: JD
authors.lastname: Molkentin
authors.forename: G P
authors.initials: GP
authors.lastname: Boivin
authors.forename: G F
authors.initials: GF
authors.lastname: Babcock
authors.forename: T
authors.initials: T
authors.lastname: Doetschman
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D019703:Calcineurin / Q000172:deficiency* / Q000276:immunology; D002454:Cell Differentiation / Q000276:immunology; D002478:Cells, Cultured; D007249:Inflammation / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D008213:Lymphocyte Activation / Q000276:immunology; D018655:Lymphocyte Count; D051379:Mice; D018345:Mice, Knockout; D013154:Spleen / Q000276:immunology; D016019:Survival Analysis; D016176:T-Lymphocyte Subsets / Q000276:immunology; D053773:Transforming Growth Factor beta1 / Q000276:immunology*
chemical_list: D053773:Transforming Growth Factor beta1; D019703:Calcineurin